Treatment of Crohn’s Disease with Cannabis: An Observational Study
IMAJ – The Israel Medical Association Journal, 2011
Timna Naftali 1, Lihi Bar Lev, Doron Yablecovitch, Elisabeth Half, Fred M Konikoff
1Institute of Gastroenterology and Hepatology, Meir Medical Center, Kfar Saba affiliated with Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel.
A groundbreaking retrospective research study interviewed 30 Crohn’s patients who was the first to participate IBD cannabis clinical study. All Patients Stated a Positive Effect on their Crohn’s Disease Activity.
STUDY POPULATION: 30 patients (26 males) with CD.
Of the 30 patients 21 improved significantly after treatment with cannabis. The average Harvey Bradshaw index improved from 14 ± 6.7 to 7 ± 4.7 (P < 0.001). The need for other medication was significantly reduced. Fifteen of the patients had 19 surgeries during an average period of 9 years before cannabis use, but only 2 required surgery during an average period of 3 years of cannabis use.